Objective: To examine the association between a lifetime history of migraines and other headaches with and without aura and Rose angina and coronary heart disease (CHD). Methods: Participants were 12,409 African American and white men and women from the Atherosclerosis Risk in Communities Study, categorized by their lifetime history of headaches lasting Ն4 hours (migraine with aura, migraine without aura, other headaches with aura, other headaches without aura, no headaches). Gender-specific associations of headaches with Rose angina and CHD, adjusted for sociodemographic and cardiovascular disease risk factors, were evaluated using Poisson regression. Results: Participants with a history of migraines and other headaches were more likely to have a history of Rose angina than those without headaches. The associations were stronger for migraine and other headaches with aura (prevalence ratio [PR] ϭ 3.0, 95% CI ϭ 2.4, 3.7 and PR ϭ 2.0, 95% CI ϭ 1.5, 2.7 for women; PR ϭ 2.2, 95% CI ϭ 1.2, 3.9 and PR ϭ 2.4, 95% CI ϭ 1.4, 3.9 for men) than for migraine and other headaches without aura (PR ϭ 1.5, 95% CI ϭ 1.2, 1.9 and PR ϭ 1.3, 95% CI ϭ 1.1, 1.6 for women; PR ϭ 1.9, 95% CI ϭ 1.2, 2.9 and OR ϭ 1.4, 95% CI ϭ 1.0, 1.8 for men). In contrast, migraine and other headaches were not associated with CHD, regardless of the presence of aura. Conclusions: The lack of association of migraines with coronary heart disease suggests that the association of migraine with Rose angina is not related to coronary artery disease. Future research assessing other common underlying pathologic mechanisms is warranted.
As many as 11 million people in the United States report a history of migraine headache. 1 Migraines are more common in women [1] [2] [3] and more prevalent at younger ages. 1, 2, 4 Both genetic 5, 6 and environmental factors may play a role in the etiology of migraines; however, the underlying pathophysiologic mechanisms have not been elucidated. Recently, research has focused on the role of neural dysfunction in the occurrence of migraines, with reports suggesting associations with dysfunction of the sympathetic nervous system 7 and dysfunction in the brainstem related to modulation of craniovascular afferents. 8 There is no consensus as to whether migraine with aura and migraine without aura are physiologically similar or distinct entities. 3 Wolff's "vascular theory" suggests vasoconstriction of intracerebral ar-teries leads to ischemia and symptoms of aura and a subsequent hyperemic response leads to vasodilation and headache pain. 9 Previous studies have reported reduced cerebral blood flow during the aura phase among those with migraine with aura 10, 11 and the persistence of reduced cerebral blood flow into the pain phase of migraine. 12 An underlying vascular component suggests the plausibility of an association between migraines and coronary heart disease (CHD). However, the literature is inconclusive. Population-based studies report both an increased occurrence of CHD among migraneurs [13] [14] [15] and no association. 16, 17 Case reports and clinical studies suggest a positive association between migraine and variant angina. [18] [19] [20] Likewise, several population-based studies found participants with migraines were more likely to report chest pain, 2, 13, 17 although no association has also been reported. 17 The previous contrasting findings may have resulted from several methodologic issues including not using standardized criteria, not classifying migraines by aura status, and reliance on self-report of outcomes. Thus, this study sought to address these issues and evaluate the association of migraine and other headaches, with and without aura, with Rose angina and verified CHD events in a large, biracial cohort of men and women. The specific study questions addressed were as follows: 1) Are persons with migraines or other headaches more likely to have a history of Rose angina or to have a CHD event or both compared with persons without headaches? 2) Does the strength of this association vary by whether the headaches include aura symptoms? 3) Do associations vary by gender?
Methods. Study population. Participants were from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort study designed to investigate the natural history of atherosclerotic disease. A detailed account of the study design and procedures has been published. 21 In brief, the study protocol included four triennial clinic examinations between 1987 and 1998 in addition to annual telephone interviews. Probability samples of men and women, ages 45 to 64, were taken in the noninstitutionalized residential population of four communities in the United States: Forsyth County, NC, northwest suburbs of Minneapolis, MN, Washington County, MD, and Jackson, MS. To ensure adequate representation, African Americans were exclusively sampled in Jackson, MS, and oversampled in Forsyth County, NC. Response rates for the initial interview and physical examination were 46% in Jackson and between 65 and 67% in the other three communities. A comparison of respondents with nonrespondents indicated that respondents were of higher socioeconomic status than nonrespondents, with more pronounced differences for whites than African Americans. Also, general health perception was more favorable among white respondents than white nonrespondents, whereas the reported health status did not vary for African Americans. 22 At the third ARIC examination (1993 to 1995), a history of headaches was ascertained. Of 12,887 participants, we excluded those who were not African American or white (n ϭ 38), African Americans in Washington County and Minneapolis (n ϭ 42), and participants with missing data on migraine (n ϭ 57) or Rose angina (n ϭ 341). After these exclusions, 12,409 participants remained for the current study. During the analysis of verified CHD incident events, participants who had prevalent CHD at baseline (n ϭ 657) or who had a history of headache that could not be confirmed to precede participation in the ARIC Study (n ϭ 973) were also excluded. Additionally, in multivariate regression analyses, those missing covariate data (n ϭ 672) were excluded.
Ascertainment of headache status. Trained interviewers asked participants about their lifetime history of headaches. Only participants reporting a history of headaches lasting Ն4 hours were eligible to answer additional headache questions. Lifetime history of migraine was defined based on a modification of the International Headache Society (IHS) diagnostic criteria. 23 The ARIC criteria were as follows: 1) Headache lasted at least 4 hours; 2) headache was accompanied by throbbing, pulsing, or pounding or was unilateral; 3) headache occurred with nausea, vomiting, or sensitivity to light or sound; 4) Ն1 years with a history of such a headache. Additionally, an affirmative response to a question about the occurrence of visual aura (i.e., spots, jagged lines, or heat waves in one or both eyes) was included to differentiate those with any history of migraine with aura from those with only a history of migraine without aura. Headaches lasting at least 4 hours but not satisfying all migraine criteria (subsequently referred to as "other headaches") were also included and subdivided by whether or not their symptoms included aura. Participants not reporting headaches of Ն4 hours' duration were classified as not having headaches. Thus, participants were classified into one of five headache categories (migraine with aura, migraine without aura, other headaches with aura, other headaches without aura, and no headaches).
Ascertainment of Rose angina and CHD status. At the first ARIC examination (1987 to 1989), trained interviewers administered the London School of Hygiene Chest Pain Questionnaire (Rose Angina Questionnaire) 24 to ascertain lifetime history of Rose angina. Subsequently, the Rose Questionnaire was administered annually during telephone interviews occurring between the triennial examinations with two modifications: Participants were asked only to report Rose angina that had occurred since they were last contacted, and when they reported chest pain, they were asked to describe, rather than point to, the location of the pain. A participant was classified as positive for Rose angina if s/he reported angina at the first examination or at least once during the annual telephone calls through the third examination. As angina reported on more than one occasion is more strongly associated with CHD than angina reported on just one occasion, 25, 26 we also performed an additional analysis, limited to those reporting positive Rose angina during more than one of the three time periods (1987 to 1989, 1990 to 1992, 1993 to 1995) .
Participants who had a CHD event between the first examination and December 1999 were classified as having a verified CHD event. Verified CHD events included hospitalized myocardial infarction (MI), silent MI, coronary revascularization procedures (coronary artery bypass grafting or percutaneous transluminal coronary angioplasty), and fatal CHD. Potential CHD hospitalizations were ascertained annually by telephone interviews and medical records review. Symptoms and cardiac enzyme levels were abstracted from hospital records. The Minnesota Code 27 was used to code up to three EKGs per hospitalization. Out-of-hospital deaths were evaluated using death certificates, family interviews, physician questionnaires, and coroner reports. Criteria used to classify CHD events in the ARIC Study have been previously described. 28 Participants were not queried about the age when their headaches first began, but information was collected about the number of years they experienced headaches. This information was used to determine if participants' headache history potentially predated their participation in the ARIC Study. Among participants without prevalent CHD at the first examination, additional analysis of the relationship between headache type and verified CHD events was done, limited to those with a headache history greater than the duration of their participation in the ARIC Study. Thus, these events were determined to first occur after the onset of headaches.
Additional covariates. Sociodemographic covariates included race (African American, white), gender, and family income (Ͻ$16,000, $16,000 to 24,999, $25,000 to 34,999, $35,000 to $49,999, $50,000 to 74,999, Ն$75,000). Cardiovascular disease (CVD) risk factors also associated with headaches in the literature were considered as covariates. These included diabetes, hypertension, total plasma cholesterol, and smoking status (ever, never), as measured at the third examination, and fibrinogen, as measured at the first examination. Diabetes was defined as a nonfasting glucose level of Ն200 mg/dL, an 8-hour fasting glucose level of Ն126 mg/dL, physician diagnosis of diabetes, or use of insulin or hypoglycemic agents during the previous 2 weeks. Blood pressure was measured three times, using a standardized protocol. The average of the second and third measures was used to classify blood pressure level. Hypertension was defined as systolic blood pressure of Ն140 mm Hg, diastolic blood pressure of Ն90 mm Hg, or use of antihypertensive medications during the previous 2 weeks. Total cholesterol was determined using an enzymatic method, and fibrinogen was measured by the thrombin-time titration method.
Statistical techniques. All statistical analyses were performed using SAS version 8.2 software (Cary, NC). 29 A macro procedure for the adjustment of proportions in logistic regression 30 was used to calculate gender-specific age-and race-adjusted prevalence estimates and 95% CIs for each group. Given that the prevalence of Rose angina and the occurrence of CHD were Ն10% in some headache strata, use of logistic regression could lead to overestimation of the relative risk due to violation of the rare disease assumption. Thus, Poisson regression was used to obtain prevalence ratios (PRs) because it has been shown to provide a more appropriate estimate of the adjusted relative risk in such circumstances. 31 To prevent underestimation of standard errors owing to overdispersion, the Pearson scale option was used. 32 Models were adjusted for sociodemographic variables (age, race, and family income) and CVD risk factors (hypertension, diabetes, smoking, total cholesterol, fibrinogen).
Results. Participant characteristics.
At the third examination (1993 to 1995), the mean age of participants was 60 years and approximately 55% were women and 20% were African American. Thirty-four percent of participants had a family income of Ͻ$25,000, whereas 30% had a family income of Ն$50,000. Fifty-nine percent of participants were current or former smokers, 15% were diabetic, and 40% were hypertensive. The mean total plasma cholesterol level was 208 mg/dL and the mean fibrinogen level was 299 mg/dL.
Prevalence of migraine and other headaches. Table 1 presents age-adjusted lifetime prevalence estimates of migraine and other headaches. Overall, 8% of participants reported a history of migraine (approximately 3% migraine with aura and 5% migraine without aura). Additionally, about 2% of participants reported a history of other headaches with aura, and 11% reported a history of other headaches lasting Ն4 hours that did not include aura. The prevalence of headaches varied markedly by gender and race. The higher prevalence of migraine without aura compared with migraine with aura, noted overall, held true for whites but not African Americans. Also, other headaches, whether accompanied by aura or not, were more common among women than men within race groups and more common among whites than African Americans within gender groups. Owing to small sample sizes of African Americans, all further analyses are presented for African Americans and whites combined.
Association of headaches with prevalent Rose angina. Overall, approximately 13% of women and 9% of men reported a history of angina through the third examination. Table 2 presents the gender-specific, age-and raceadjusted prevalence estimates of Rose angina by headache type as well as the risk factor-adjusted PRs. Among both men and women, there were statistically significant and marked increases in the prevalence of Rose angina among those with migraine with aura and other headaches with aura compared with those with no headache. More modest increases in the prevalence of Rose angina were also reported among those with headaches without aura.
After adjusting for age, race, family income, hypertension, smoking status, diabetes, total cholesterol, and fibrinogen, both men and women with migraine with aura and other headaches with aura had between a two-and threefold greater prevalence of Rose angina than did those in the noheadache group. More modest increases were also noted in the migraine without aura and the other headache without aura groups compared with the no-headache group. Additional analyses restricted to participants who reported Rose angina on multiple occasions were done. For both men and women, the magnitude of the PR was substantially increased in the migraine with aura group (PR ϭ 5.8 vs 3.0 for women and PR ϭ 3.9 vs 2.2 for men). For the other headache types, the PRs did not change substantially for either gender (data not shown).
As both headache type and Rose angina are based on the self-report of symptoms, it is plausible that the association between migraines and Rose angina may be due to a greater propensity of those with headaches to report pain than those without headaches. To further explore this is-sue, we examined associations of headaches with different types of chest pain (Rose angina, other exertional chest pain not meeting all of the Rose angina criteria, and nonexertional chest pain) as reported at the first examination (table 3) . Among both men and women, those with a history of headaches were more likely to report a history of all three types of chest pain than were those without a history of headaches. For nonexertional chest pain, this association did not vary across headache types and was weak in women and moderate in men. For Rose angina and other exertional chest pain not meeting Rose criteria, associations tended to be moderate for headaches without aura and stronger for migraine and other headaches with aura, with marked differences in women. Association of headaches with verified CHD events. Table 4 presents the age-and race-adjusted prevalence rates of verified CHD events for each headache type as well as the risk factor-adjusted PRs. For both gender groups, the percentage of verified CHD events was not significantly higher for any of the headache groups compared with the no-headache groups. In fact, proportionately fewer CHD events occurred among men with other headache without aura compared with men with no headache. After adjusting for age, race, income, and CVD risk factors, for both gender groups, there was not a significant increase in prevalence of verified CHD events for any of the headache types compared with the no-headache group. A modest, but significant, decrease in the prevalence of verified CHD events was noted for men with other headaches without aura. Analyses were repeated, restricting CHD events to those that were determined to have occurred after the onset of headache, and the results did not change substantially. Furthermore, additional analysis to evaluate current use of selected medications related to headaches or CHD or both (e.g., aspirin, nonsteroidal antiinflammatory agents, ␤-blockers, nitroglycerin) only slightly attenuated the results (data not shown).
Discussion. In the current population-based study of aging African American and white adults, participants with a lifetime history of migraine or other headaches were more likely to have a history of Rose angina than were those without a history of headaches. These associations were consistently stronger for headaches with aura symptoms, did not vary markedly by gender, and were not explained by traditional CVD risk factors. In contrast, there was no evidence of an association between a lifetime history of migraine or other headaches, regardless of aura status, and verified CHD events. Our findings of a higher prevalence of Rose angina among persons with headache are consistent in direction with several earlier studies reporting a higher prevalence of angina or chest pain among migraineurs. 13, 17 Our findings of the lack of an association of migraine and other headaches with CHD are not consistent with several previous studies, which reported an increased occurrence of CHD among those with migraines. [13] [14] [15] However, these studies were based on self-report of CHD. In contrast, CHD was limited to verified events in our study. In the two studies reviewed that also used verified CHD events, a lack of an association between migraines and CHD was also reported. 16, 17 The exploratory analysis of types of chest pain reported earlier suggests that a greater propensity to report pain explains some of the association between migraine and other headaches and chest pain. However, the stronger associations noted between headaches that included aura symptoms and both Rose angina and other exertional chest pain not meeting Rose criteria suggest other mechanisms are involved. Whether migraine with and without aura represent different underlying physiologic processes is still de-bated, although the role of a neuroelectrical event similar to cortical spreading depression has been suggested for aura. 33 Thus, although the differential association with Rose angina by aura status is intriguing, the potential biologic mechanism has not been elucidated.
Reports of a co-occurrence of migraine headaches, variant angina, and Raynaud syndrome 18, 34 have led to the hypothesis that a generalized vasospastic disorder may underlie these conditions. However, a pathophysiologic link between migraines and exertional angina is more elusive, given the absence of a similar association of migraines with CHD. In the ARIC Study, Rose angina was moderately associated with prevalent CHD; this association was stronger when the Rose angina was indicated on more than one determination. 26 Other studies have reported that angina, as defined by the Rose Angina Questionnaire or by physician diagnosis, does not always lead to a diagnosis of underlying coronary artery disease, particularly among women. 35, 36 Exertional and vasospastic angina co-exist in some individuals. 37 Whereas functional and structural changes associated with atherosclerosis are thought to lead to the ischemia resulting in exertional angina, dysfunction of vascular tone, 37 perhaps specific to the endothelium or the microvasculature, 38 may be involved.
Also, there is limited evidence that migraineurs 39, 40 and those with angina 41 have altered cardiovascular reactivity in response to physiologic or psychological stressors. Autonomic dysfunction may be related to exertional angina due to coronary artery disease and other vascular disorders 42 as well as migraines. 43 At the molecular level, autonomic dysfunction involving reduced levels or altered sensitivity to nitric oxide may be a component of both vasospasm-related chest pain 44 and typical angina. 45 Research suggests that hypersensitivity to nitric oxide may also trigger migraine pain. 46 Even still, neural dysfunction mechanisms are also currently being investigated as a possible precipitating factor in the occurrence of migraines. 7, 8 This study has several limitations that warrant discussion. Although the sample size was relatively large, there was limited power for CHD outcomes due to stratification by gender and headache status. Also, the assessment of aura symptoms was limited to IHS rapid-onset aura. 23 We were also unable to identify those with a history of aura without headache as only participants who reported a history of headaches lasting Ն4 hours were queried about the occurrence of aura. This condition would be important to include in future research endeavors, given the particularly strong associations noted with aura in the current study.
Several pharmacologic agents used to treat migraine may also affect the occurrence of CHD-related outcomes. For example, prophylactic use of ␤-blockers among migraineurs could decrease the likelihood of Rose angina as well as myocardial infarctions; similarly, prophylactic aspirin use for ei-ther headache or cardioprotection is common. Whereas current use of selected medications (i.e., nitroglycerine, ␤-blockers, aspirin, and nonsteroidal anti-inflammatory drugs) only marginally attenuated our results, we cannot exclude the possibility that prior use of these agents may have influenced the associations of interest. Pharmacologic agents used to treat migraines, such as ergotamines and triptans, have also been associated with the occurrence of chest pain 47 and coronary events. 48 However, these medications did not affect our results because the introduction of triptans did not occur until the mid-1990s, after our data had been collected, and the two participants who were using ergotamines at the time when headache history was ascertained did not have Rose angina or CHD.
As history of headache was not ascertained until the third examination, those who died prior to this examination could not be included in analyses. If those with headaches were more likely to die than those without headaches and if the migraine-CHD association differed for fatal and nonfatal events, this could bias results. Likewise, lifetime history of migraine was not ascertained in our participants until relatively late in life (average age 60 years). Selective survival due to fatal co-morbid conditions, recall error of headache symptoms, or cohort differences in the reporting of headache symptoms may have led to an underascertainment of migraines in our study. 49 Assuming this bias was nondifferential, our results may have been biased to the null.
Also, we were unable to verify temporality in the association between headaches and both angina and CHD because of when headache history was ascertained. However, as typical age at onset for migraines is in early adulthood and the typical age at onset for manifest coronary disease is later in adulthood, this would suggest that migraines likely occurred prior to the first episode of angina or CHD event. In analyses restricted to participants who experienced a CHD event after the reported onset of headaches, no association was observed. The persistent lack of association between migraines and CHD suggests that any association of migraine (with aura) and angina is not related to underlying coronary artery disease. Future research assessing common underlying pathologic mechanisms is important in the interpretation of these findings.
